Sellas Life Sciences Group Inc (NASDAQ: SLS) shares are trading lower by 52.57% to $1.75 Friday morning after the company announced pricing of a $20 million underwritten public offering.
What Else?
Infobird Co., Ltd (NASDAQ:IFBD) ("Infobird" or the "Company"), a leading and long-standing SaaS providers in serving large enterprises in the finance industry in customer engagement with over 10
Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases
Apellis Pharmaceuticals, Inc., (NASDAQ:APLS), a global biopharmaceutical company and leader in complement, today announced the pricing of its underwritten public offering of 3,174,603 shares of its common
Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response
Quoin Pharmaceuticals Ltd - ADR (NASDAQ: QNRX) shares are trading lower by 42.82% to $0.68 Wednesday morning. The company announced pricing of its $7 million public offering.
What Else?
Verrica announced the pricing of its underwritten offering of 750,000 shares of its common stock and pre-funded warrants to purchase 4,064,814 shares of common stock. The shares of common stock are being sold at a price